top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Gastrointestinal Cancers: An Interdisciplinary Approach [[electronic resource] /] / edited by Nima Rezaei
Gastrointestinal Cancers: An Interdisciplinary Approach [[electronic resource] /] / edited by Nima Rezaei
Autore Rezaei Nima
Edizione [1st ed. 2023.]
Pubbl/distr/stampa Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023
Descrizione fisica 1 online resource (405 pages)
Disciplina 571.978
616.994
Collana Interdisciplinary Cancer Research
Soggetto topico Cancer
Cancer - Treatment
Oncology
Immunotherapy
Tumors - Immunological aspects
Nanomedicine
Gastrointestinal Neoplasms
Tumor Microenvironment
Cancer Biology
Cancer Therapy
Tumour Immunology
Cancer Nanotechnology
ISBN 3-031-48371-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Interdisciplinary Approach in Gastrointestinal Cancers -- Gastrointestinal Cancers: What Is the Real Board of Microenvironment and the Role of Microbiota-Immunity Axis -- Epithelial-Mesenchymal Transition in Gastrointestinal Cancer: From a Basic to a Clinical Approach -- Metabolomics of Gastrointestinal Cancers -- Deregulation of Immune System in Gastric Cancer Development, How Immune Nutrition Might Restore the Functions of Immune Cells -- Helicobacter pylori Virulence Factors, Pathogenicity, and Gastric Cancer -- Gastric Cancer and Helicobacter pylori -- Role of Neuromodulators in Regulation of the Tumor Microenvironment of Gastric and Colorectal Cancers -- The Role of Tumor Microenvironment in Colon Cancer -- Unraveling the Esophageal Cancer Tumor Microenvironment: Insights and Novel Immunotherapeutic Strategies -- The Interplay Between Immunity and Gut Microbiota in Colon Cancer -- Immunotherapy in Gastrointestinal Cancer Focusing on CAR-T Cell Therapy -- Development of Biocompatible Nanocarriers for the Treatment of Colorectal Cancer -- Challenges of Onco-therapeutics in Early Onset Colorectal Cancer -- Unintentional Weight Loss and Malnutrition After Esophageal Cancer and Treatment -- Current Clinical Landscape of Immunotherapeutic Approaches in Pancreatic Cancer Treatment. The Tumor Microenvironment in Pancreatic Cancer and Challenges to Immunotherapy. .
Record Nr. UNINA-9910799498103321
Rezaei Nima  
Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Hepatobiliary Cancers: An Interdisciplinary Approach [[electronic resource] /] / edited by Nima Rezaei
Hepatobiliary Cancers: An Interdisciplinary Approach [[electronic resource] /] / edited by Nima Rezaei
Edizione [1st ed. 2023.]
Pubbl/distr/stampa Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023
Descrizione fisica 1 online resource (XI, 365 p. 22 illus., 21 illus. in color.)
Disciplina 571.978
616.994
Collana Interdisciplinary Cancer Research
Soggetto topico Cancer
Cancer - Treatment
Tumors - Immunological aspects
Immunotherapy
Cancer - Genetic aspects
Stem cells
Stem Cells
Digestive System Diseases
Carcinoma, Hepatocellular - therapy
Liver Neoplasms - therapy
Biliary Tract Neoplasms - therapy
Cancer Biology
Cancer Therapy
Tumour Immunology
Cancer Genetics and Genomics
Cancer Stem Cells
ISBN 3-031-44528-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Interdisciplinary Approach in Hepatobiliary Cancers -- Liver Cancer: Interdisciplinary Approach -- The Immune System in Liver Cancer: From Beginning to Progression -- The Tumor Microenvironment in Hepatocellular Carcinoma -- Metabolic Alterations of Hepatocellular Cancer Stem Cells -- Τhe Role of Senescence in NASH-related HCC -- Regulators of Genetic Risk for the Progression of Non-alcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Reconstruction of Transcriptional Network and Signature-Based Metabolic Profiling -- Tumor Microenvironment and Immunotherapy in Advanced Biliary Tract Cancers -- Fibrosis and Immunotherapy in Hepatocellular Carcinoma -- Liver Cancer and the Curative Potential of Nanomedicine -- Locoregional Therapies for Hepatocellular Carcinoma -- Drug Resistance in Hepatocellular Carcinoma -- Liver Stereotactic Body Radiotherapy.
Record Nr. UNINA-9910799245703321
Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunopotentiation
Immunopotentiation
Pubbl/distr/stampa Amsterdam, : Elsevier, 1973
Descrizione fisica 1 online resource (368 pages)
Disciplina 574.2/9
Collana Ciba Foundation symposium (new series)
Soggetto topico Immunological adjuvants
Tumors - Immunological aspects
ISBN 1-280-78336-2
9786613693754
0-470-72001-8
0-470-71768-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Immunopotentiation; Contents; Introduction; The cellular targets for the action of adjuvants : T-adjuvants and B-adjuvants; Discussion; The relation of lymphocyte trapping to the mode of action of adjuvants; Discussion; Immunopotentiation by mycobacteria in complete Freund-type adjuvant as the failure of normal immunological homeostasis; Discussion; Effects of adjuvants on different cell types and their interactions in immune responses; Discussion; Cellular mechanisms underlying the adjuvant activity of Corynebacterium parvurn: interactions of activated macrophages with T and B lymphocytes
DiscussionChemotaxis of macrophages : the role of a macrophage-specific cytotaxin from anaerobic corynebacteria and its relation to immunopotentiation in vivo; Discussion; The allogeneic effect on the immune system and its potential applications to tumour immunity; Discussion; Mitogens as probes for immunocyte activ- ation : specific and non-specific paralysis of B cell mitogenesis; Discussion; General Discussion I The T cell-deprived mouse; The use of viruses as immunological potentiators; Discussion
Corynebacterium parvum, a potent immunostimu-lant in experimental infections and in malignanciesDiscussion; Orchidectomy as a method of immunopotentiation in mice; Discussion; The nature of immunopotentiation by the anti-tumour polysaccharide lentinan and the significance of biogenic amines in its action; Discussion; The effect of Corynebacterium parvum and other reticuloendothelial stimulants on transplanted tumours in mice; Discussion; Attempt at using systemic immunity adjuvants in experimental and human cancer therapy; Discussion
General Discussion II Restoration of immune capability in cancer patientsSites of action of adjuvants; Conclusion; Index of contributors; Subject index
Record Nr. UNINA-9910144663403321
Amsterdam, : Elsevier, 1973
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunopotentiation
Immunopotentiation
Pubbl/distr/stampa Amsterdam, : Elsevier, 1973
Descrizione fisica 1 online resource (368 pages)
Disciplina 574.2/9
Collana Ciba Foundation symposium (new series)
Soggetto topico Immunological adjuvants
Tumors - Immunological aspects
ISBN 1-280-78336-2
9786613693754
0-470-72001-8
0-470-71768-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Immunopotentiation; Contents; Introduction; The cellular targets for the action of adjuvants : T-adjuvants and B-adjuvants; Discussion; The relation of lymphocyte trapping to the mode of action of adjuvants; Discussion; Immunopotentiation by mycobacteria in complete Freund-type adjuvant as the failure of normal immunological homeostasis; Discussion; Effects of adjuvants on different cell types and their interactions in immune responses; Discussion; Cellular mechanisms underlying the adjuvant activity of Corynebacterium parvurn: interactions of activated macrophages with T and B lymphocytes
DiscussionChemotaxis of macrophages : the role of a macrophage-specific cytotaxin from anaerobic corynebacteria and its relation to immunopotentiation in vivo; Discussion; The allogeneic effect on the immune system and its potential applications to tumour immunity; Discussion; Mitogens as probes for immunocyte activ- ation : specific and non-specific paralysis of B cell mitogenesis; Discussion; General Discussion I The T cell-deprived mouse; The use of viruses as immunological potentiators; Discussion
Corynebacterium parvum, a potent immunostimu-lant in experimental infections and in malignanciesDiscussion; Orchidectomy as a method of immunopotentiation in mice; Discussion; The nature of immunopotentiation by the anti-tumour polysaccharide lentinan and the significance of biogenic amines in its action; Discussion; The effect of Corynebacterium parvum and other reticuloendothelial stimulants on transplanted tumours in mice; Discussion; Attempt at using systemic immunity adjuvants in experimental and human cancer therapy; Discussion
General Discussion II Restoration of immune capability in cancer patientsSites of action of adjuvants; Conclusion; Index of contributors; Subject index
Record Nr. UNISA-996202085603316
Amsterdam, : Elsevier, 1973
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Immunopotentiation
Immunopotentiation
Pubbl/distr/stampa Amsterdam, : Elsevier, 1973
Descrizione fisica 1 online resource (368 pages)
Disciplina 574.2/9
Collana Ciba Foundation symposium (new series)
Soggetto topico Immunological adjuvants
Tumors - Immunological aspects
ISBN 1-280-78336-2
9786613693754
0-470-72001-8
0-470-71768-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Immunopotentiation; Contents; Introduction; The cellular targets for the action of adjuvants : T-adjuvants and B-adjuvants; Discussion; The relation of lymphocyte trapping to the mode of action of adjuvants; Discussion; Immunopotentiation by mycobacteria in complete Freund-type adjuvant as the failure of normal immunological homeostasis; Discussion; Effects of adjuvants on different cell types and their interactions in immune responses; Discussion; Cellular mechanisms underlying the adjuvant activity of Corynebacterium parvurn: interactions of activated macrophages with T and B lymphocytes
DiscussionChemotaxis of macrophages : the role of a macrophage-specific cytotaxin from anaerobic corynebacteria and its relation to immunopotentiation in vivo; Discussion; The allogeneic effect on the immune system and its potential applications to tumour immunity; Discussion; Mitogens as probes for immunocyte activ- ation : specific and non-specific paralysis of B cell mitogenesis; Discussion; General Discussion I The T cell-deprived mouse; The use of viruses as immunological potentiators; Discussion
Corynebacterium parvum, a potent immunostimu-lant in experimental infections and in malignanciesDiscussion; Orchidectomy as a method of immunopotentiation in mice; Discussion; The nature of immunopotentiation by the anti-tumour polysaccharide lentinan and the significance of biogenic amines in its action; Discussion; The effect of Corynebacterium parvum and other reticuloendothelial stimulants on transplanted tumours in mice; Discussion; Attempt at using systemic immunity adjuvants in experimental and human cancer therapy; Discussion
General Discussion II Restoration of immune capability in cancer patientsSites of action of adjuvants; Conclusion; Index of contributors; Subject index
Record Nr. UNINA-9910829168903321
Amsterdam, : Elsevier, 1973
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunotherapy Against Lung Cancer [[electronic resource] ] : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua
Immunotherapy Against Lung Cancer [[electronic resource] ] : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua
Autore Bhatt Shvetank
Edizione [1st ed. 2023.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023
Descrizione fisica 1 online resource (393 pages)
Disciplina 616.994
Altri autori (Persone) EriRajaraman Eri
GohBey-Hing
PaudelKeshav Raj
Andreoli PintoTerezinha de Jesus
DuaKamal
Soggetto topico Cancer - Treatment
Tumors - Immunological aspects
Cancer Therapy
Tumour Immunology
ISBN 981-9971-41-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1_An introduction to Lung cancer -- Chapter 2_Immunobiology of Lung cancer -- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy -- Chapter 4_Recent advances in the immunotherapy of Lung cancer -- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer -- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer -- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer -- Chapter 9_IDO and TGF-β inhibitors for the treatment of Lung cancer -- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer -- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer -- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.-Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer -- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy -- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer -- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer -- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer -- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer.
Record Nr. UNINA-9910845494503321
Bhatt Shvetank  
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunotherapy Against Lung Cancer [[electronic resource] ] : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua
Immunotherapy Against Lung Cancer [[electronic resource] ] : Emerging Opportunities and Challenges / / edited by Shvetank Bhatt, Rajaraman Eri Eri, Bey-Hing Goh, Keshav Raj Paudel, Terezinha de Jesus Andreoli Pinto, Kamal Dua
Autore Bhatt Shvetank
Edizione [1st ed. 2023.]
Pubbl/distr/stampa Springer Nature Singapore, 2023
Descrizione fisica 1 online resource (393 pages)
Disciplina 616.994
Altri autori (Persone) EriRajaraman Eri
GohBey-Hing
PaudelKeshav Raj
Andreoli PintoTerezinha de Jesus
DuaKamal
Soggetto topico Cancer - Treatment
Tumors - Immunological aspects
Cancer Therapy
Tumour Immunology
ISBN 981-9971-41-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1_An introduction to Lung cancer -- Chapter 2_Immunobiology of Lung cancer -- Chapter 3_Evolution of Lung cancer treatment from classical chemotherapy to advanced immunotherapy -- Chapter 4_Recent advances in the immunotherapy of Lung cancer -- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung cancer -- Chapter 6_CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 7_Adoptive T cell therapy for the treatment of Lung cancer -- Chapter 8_LAG-3 inhibitors for the treatment of Lung cancer -- Chapter 9_IDO and TGF-β inhibitors for the treatment of Lung cancer -- Chapter 10_OX40 and CD40 agonists for the treatment of Lung cancer -- Chapter 11_ICOS and GITR agonists for the treatment of Lung cancer -- Chapter 12_Vaccines and oncolytic virus for the treatment of Lung cancer.-Chapter 13_Targeting Toll-like receptors for the treatment of Lung cancer -- Chapter 14_Current and future perspectives of combining chemotherapy and stereotactic body radiation therapy with immunotherapy -- Chapter 15_Synergistic potential of PD-1/PD-L1 inhibitors and CTLA-4 inhibitors for the treatment of Lung cancer -- Chapter 16_Synergistic potential of antigen-specific vaccines and immunomodulatory agents for the treatment of Lung cancer -- Chapter 17_Important biomarkers for better evaluation of checkpoint inhibitors and another immunotherapy in Lung cancer -- Chapter 18_Insight on the clinical trials of immunotherapy for the treatment of Lung cancer -- Chapter 19_Future perspectives of the Cancer Immunotherapy for the treatment of Lung cancer.
Record Nr. UNINA-9910853990503321
Bhatt Shvetank  
Springer Nature Singapore, 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Interaction of Immune and Cancer Cells [[electronic resource] /] / edited by Magdalena Klink, Izabela Szulc-Kielbik
Interaction of Immune and Cancer Cells [[electronic resource] /] / edited by Magdalena Klink, Izabela Szulc-Kielbik
Edizione [2nd ed. 2022.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022
Descrizione fisica 1 online resource (358 pages)
Disciplina 616.994079
Collana Experientia Supplementum
Soggetto topico Tumors - Immunological aspects
Cancer - Treatment
Oncology
Tumour Immunology
Cancer Therapy
Cèl·lules T
Anticossos monoclonals
Oncologia
Càncer
Immunoteràpia
Soggetto genere / forma Llibres electrònics
ISBN 3-030-91311-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chapter 1: Cancer immunoediting - elimination, equilibrium and immune escape in solid tumors -- Chapter 2: Tumor – Stroma Interaction and Cancer. - Chapter 3: Tumor-infiltrating lymphocytes and their role in solid tumor progression -- Chapter 4: Tumor-associated macrophages – reasons to be cheerful, reasons to be fearful -- Chapter 5: Polymorphonuclear neutrophils and tumors: friend or foe? -- Chapter 6: Role of NK cells in tumor progression -- Chapter 7: The role of myeloid-derived suppressor cells in tumor growth and metastasis -- Chapter 8: Cancer stem cells – an ever hiding foe -- Chapter 9: Adoptive T-cell immunotherapy – Perfecting self-defenses -- Chapter 10: Monoclonal antibodies to CTLA-4 with focus on ipilimumab.
Record Nr. UNINA-9910544846103321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Journal for immunotherapy of cancer
Journal for immunotherapy of cancer
Pubbl/distr/stampa London : , : BioMed Central, , 2013-
Descrizione fisica 1 online resource
Soggetto topico Cancer - Immunotherapy
Cancer - Immunological aspects
Tumors - Immunological aspects
Immunotherapy
Neoplasms - immunology
Neoplasms - therapy
Càncer
Tumors
Soggetto genere / forma Periodical
Fulltext
Internet Resources.
Periodicals.
Revistes electròniques.
Soggetto non controllato Oncology
ISSN 2051-1426
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti JITC
Record Nr. UNISA-996210782303316
London : , : BioMed Central, , 2013-
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Journal for immunotherapy of cancer
Journal for immunotherapy of cancer
Pubbl/distr/stampa London : , : BioMed Central, , 2013-
Descrizione fisica 1 online resource
Soggetto topico Cancer - Immunotherapy
Cancer - Immunological aspects
Tumors - Immunological aspects
Immunotherapy
Neoplasms - immunology
Neoplasms - therapy
Càncer
Tumors
Soggetto genere / forma Periodical
Fulltext
Internet Resources.
Periodicals.
Revistes electròniques.
Soggetto non controllato Oncology
ISSN 2051-1426
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti JITC
Record Nr. UNINA-9910141849503321
London : , : BioMed Central, , 2013-
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui